• OPEN AN ACCOUNT
Indian Indices
Nifty
24,793.25 -18.80
(-0.08%)
Sensex
82,408.17 1,046.30
( 1.29%)
Bank Nifty
55,577.45 -251.30
( -0.45%)
Nifty IT
38,664.95 -365.95
( -0.94%)
Global Indices
Nasdaq
42,197.27 -39.54
(-0.09%)
Dow Jones
6,001.75 -1.97
(-0.03%)
Hang Seng
38,498.24 9.90
(0.03%)
Nikkei 225
8,791.80 -51.67
(-0.58%)
Forex
USD-INR
86.44 0.19
(0.22%)
EUR-INR
99.39 -0.08
(-0.08%)
GBP-INR
116.19 -0.40
(-0.35%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
101.444166
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
92.29
395254.45
EPS(TTM)
Face Value()
Div & Yield %
17.85
1
0.97
 

sun pharmaceuticals industries ltd
Sun Pharma updates on US FDA inspection
Jun 14,2025
Sun Pharmaceutical Industries has informed that the US FDA conducted a Good Manufacturing Practices (GMP) inspection of Sun Pharmaceutical Industries Limited's Halol facility (Gujarat, India) from 02 June to 13 June 2025. At the conclusion of the inspection, the US FDA issued a Form-483, with 8 observations.